Blog

admedicum recently moderated another pharma-patient forum about „Patient Engagement in pharmaceutical R&D“. Our client, a pharmaceutical company, had invited advocates from a number of German patient groups, both for common and rare diseases. Joint working groups facilitated for an exchange mainly on expectations, suggestions and concerns on behalf of the patient advocates with regard to collaboration with the company ...

Search the blog